Kimberly-Clark (KMB) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
2 Feb, 2026Executive summary
Achieved strong volume-plus-mix growth and global weighted share gains, with Q4 and FY25 showing robust performance in both North America and International Personal Care segments.
Delivered solid operating profit and stable earnings, supported by productivity, cost management, and reinvestment in brands and capabilities.
Focused on consumer-directed innovation, cost discipline, and margin optimization, with a strategic pivot to higher growth, higher-margin personal care categories.
Announced the acquisition of Kenvue, expected to create a $32 billion global health and wellness leader, with anticipated $2.1B in EBITDA synergies and accretive adjusted EPS by year 2.
Transformation initiatives and portfolio shifts, including business exits and the IFP transaction, are expected to drive long-term value.
Financial highlights
Q4 organic sales up 2.1%, with FY25 organic sales growth at 1.7%; Q4 adjusted operating profit up 13.1%, adjusted EPS up 24%.
Full-year adjusted operating profit was $2.7B, flat year-over-year; adjusted EPS up 3.2% to $7.53.
Adjusted free cash flow for FY25 was $1.9B; cash from operations was $2.8B.
Gross productivity savings reached 6.2% of adjusted COGS for FY25, exceeding the 5-6% target.
Adjusted gross margin improved by 70 bps to 37.3% in FY25.
Outlook and guidance
2026 organic sales growth expected to be in line or ahead of category averages (~2%), with mid- to high-single digit constant-currency adjusted operating profit growth and double-digit constant-currency adjusted EPS growth from continuing operations.
Adjusted free cash flow expected to be ~$2B in 2026, with capital expenditures accelerating to ~$1.3B.
Expect margin expansion in 2026, with gross margin targeted to reach at least 40% before 2030 and operating profit margin 18%-20%.
Innovation and brand support to ramp up through Q1 and Q2, with organic growth accelerating in the back half of the year.
Adjusted EPS attributable to the company expected to be flat due to reduced discontinued operations income.
Latest events from Kimberly-Clark
- Transformation, innovation, and Kenvue integration drive global growth and value creation.KMB
Consumer Analyst Group of New York Conference (CAGNY) 202619 Feb 2026 - Strong FY25 growth, margin gains, and Kenvue deal set stage for higher returns in 2026.KMB
Q4 2025 Prepared Remarks3 Feb 2026 - Issuance of common stock for a merger was approved; final results to be filed with the SEC.KMB
AGM 20263 Feb 2026 - Q2 profit and EPS surged on organic growth, innovation, and raised full-year outlook.KMB
Q2 2024 Prepared Remarks3 Feb 2026 - Q2 organic sales up 5% and adjusted EPS up 19%-20%, with 2024 outlook raised.KMB
Q2 2024 (Q&A)3 Feb 2026 - Double-digit returns targeted through innovation, premiumization, and operational efficiency.KMB
Deutsche Bank dbAccess 2024 Global Consumer Conference31 Jan 2026 - Balanced matrix reorganization and supply chain overhaul drive growth and efficiency.KMB
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Q3 2024 delivered higher adjusted EPS and profit, reaffirming a strong 2024 outlook.KMB
Q3 202419 Jan 2026 - Transformation and innovation drive growth, with strategic exits supporting long-term brand focus.KMB
Morgan Stanley Global Consumer & Retail Conference12 Jan 2026